Super Micro Computer, Inc. (SMCI)

Elevation Oncology Stock Forecast

Stock Price Forecast

The 16 analysts that cover Elevation Oncology stock have a consensus rating of "Buy" and an average price target of $46.62, which forecasts a -0.11% decrease in the stock price over the next year. The lowest target is $34 and the highest is $70.

Price Target: $46.62 (-0.11%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$34	$46.62	$45.4	$70
Change	-27.15%	-0.11%	-2.72%	+49.99%

Analyst Ratings

The average analyst rating for Elevation Oncology stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	4	4	4	4	4	4
Buy	1	1	2	2	2	2
Hold	11	11	11	12	10	11
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	17	17	18	19	17	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tim Long Barclays	Barclays	Hold Maintains $29 → $45	Hold	Maintains	$29 → $45	-3.58%	Aug 7, 2025
Samik Chatterjee JP Morgan	JP Morgan	Hold Maintains $46 → $45	Hold	Maintains	$46 → $45	-3.58%	Aug 6, 2025
Matt Bryson Wedbush	Wedbush	Hold Maintains $30 → $48	Hold	Maintains	$30 → $48	+2.85%	Aug 6, 2025
N. Quinn Bolton Needham	Needham	Strong Buy Maintains $39 → $60	Strong Buy	Maintains	$39 → $60	+28.56%	Aug 6, 2025
Matt Bryson Wedbush	Wedbush	Hold Reiterates $30	Hold	Reiterates	$30	-35.72%	Aug 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

30.54B

Increased by 38.99%

from 21.97B

Revenue Next Year

38.21B

Increased by 25.12%

from 30.54B

EPS This Year

2.82

Increased by 68.03%

from 1.68

EPS Next Year

4.02

Increased by 42.56%

from 2.82

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027	Jun 30, 2028
Revenue	3.56B	5.20B	7.12B	14.99B	21.97B	30.54B	38.21B	20.09B
Revenue Growth	6.53%	46.06%	37.09%	110.42%	46.59%	38.99%	25.12%	-47.43%
EPS	0.21	0.53	1.14	1.92	1.68	2.82	4.02	-
EPS Growth	30.63%	153.59%	115.09%	68.13%	-12.45%	68.03%	42.56%	-
Forward PE	-	-	-	-	-	16.55	11.61	-
No. Analysts	-	-	-	-	-	21	14	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029
High	37.9B	47.9B	20.7B
Avg	30.5B	38.2B	20.1B
Low	24.5B	30.7B	19.3B

Revenue Growth

Revenue Growth	2026	2027	2028	2029
High	72.6%	56.9%	-45.9%
Avg	39.0%	25.1%	-47.4%
Low	11.5%	0.5%	-49.5%

EPS Forecast

EPS	2026	2027
High	3.52	4.60
Avg	2.82	4.02
Low	1.93	2.84

EPS Growth

EPS Growth	2026	2027
High	109.6%	63.1%
Avg	68.0%	42.6%
Low	14.8%	0.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.